| Breakdown | TTM | Sep 2025 | Sep 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.86M | 92.22M | 86.59M | 67.51M | 62.81M | 54.50M |
| Gross Profit | 47.15M | 61.45M | 28.78M | 17.81M | 42.65M | 40.04M |
| EBITDA | 32.00M | 18.02M | 20.31M | 9.96M | 9.92M | 10.40M |
| Net Income | 12.16M | 10.62M | 9.86M | 1.67M | 5.35M | 5.23M |
Balance Sheet | ||||||
| Total Assets | 97.14M | 101.84M | 97.14M | 91.33M | 70.33M | 68.58M |
| Cash, Cash Equivalents and Short-Term Investments | 27.17M | 30.84M | 27.17M | 15.80M | 29.27M | 34.34M |
| Total Debt | 4.24M | 3.13M | 4.24M | 5.48M | 3.24M | 3.76M |
| Total Liabilities | 23.98M | 21.18M | 23.98M | 26.18M | 9.11M | 16.30M |
| Stockholders Equity | 73.16M | 80.66M | 73.16M | 65.15M | 61.23M | 52.28M |
Cash Flow | ||||||
| Free Cash Flow | 24.02M | 14.68M | 16.98M | 5.20M | -3.62M | 11.68M |
| Operating Cash Flow | 25.41M | 15.16M | 17.44M | 7.20M | -1.40M | 12.33M |
| Investing Cash Flow | -24.15M | -5.43M | -4.15M | -19.61M | -2.22M | 556.00K |
| Financing Cash Flow | -2.58M | -6.04M | -1.64M | -943.00K | -1.45M | 14.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £84.74M | 77.50 | 5.28% | 0.60% | 1.92% | -75.53% | |
65 Neutral | £138.60M | 18.54 | 24.52% | 1.09% | -21.19% | -29.54% | |
64 Neutral | £114.99M | 19.41 | 13.81% | ― | ― | ― | |
63 Neutral | £261.19M | 10.45 | 6.22% | 0.53% | -6.22% | -6.69% | |
62 Neutral | £191.88M | -1.32 | -21.91% | 11.37% | -4.44% | 19.95% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | £231.72M | -5.55 | -4.92% | 6.33% | -14.27% | -15466.67% |